The Anticoccidial Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of anticoccidial drugs has seen substantial growth in recent years. It is projected to increase from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The historical growth trend in the Anticoccidial Drugs market has been upward.
The Anticoccidial Drugs market is predicted to grow to a size of $1.81 billion by the year 2029, with a compound annual growth rate (CAGR) of 7.2%.
Download Your Free Sample of the 2025 Anticoccidial Drugs Market Report and Uncover Key Trends Now!The drivers in the anticoccidial drugs market are:
• Rising incidence of coccidiosis worldwide
• Increased ownership of pet animals
• High prevalence and economic impact of coccidiosis
• Growing safety concerns about food and health of animals
The anticoccidial drugs market covered in this report is segmented –
1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels
The trends in the anticoccidial drugs market are:
• The demand for anticoccidial drugs is surging due to the emergence of new coccidiosis strains.
• There's a notable trend towards natural and alternative treatment methods in the market.
• Increased regulatory scrutiny is stimulating innovation within the industry.
• Consumer preference for antibiotic-free poultry products is shaping the market trends.
The major players in the anticoccidial drugs market are:
• Johnson & Johnson
• Merck and Co
North America was the largest region in the anticoccidial drugs market in 2023